Conduent Inc Dossier - Source-backed chat

Conduent Inc

CNDTNASDAQ

SectorIndustrials

IndustryData Processing & Outsourced Services

Beta (adjusted)1.29

Intrinsic Value

Insufficient data for a value estimateNot enough reliable inputs to publish a fair value for this company yet.

Market Price $1.64Price as of 1 Oct 2026

Data confidenceNot applicable

Market Cap $255.1M

Enterprise Value $718.1M

Shares Outstanding 152.1M diluted

Moat Rating None

Next Earnings Date6 Nov 2026

All prices and values are periodic snapshots, not live quotes. Source dates are shown for reference.

Thesis

Street consensus, scenarios, merits, risks, and invalidation triggers

AI-assisted

Thesis Summary

Conduent is executing a multi-faceted turnaround strategy centered on portfolio simplification, cost reduction, and technological modernization. The recently announced agreement to sell its Public Transit business to Modaxo for $164 million represents a major step in its 'fix, sell, or grow' strategy, allowing the company to sharpen its focus on core operations like Tolling and Government services while strengthening its balance sheet. Furthermore, the appointment of Adam Demuyakor to the Board of Directors brings valuable expertise in generative AI and enterprise modernization. However, the company continues to face headwinds, including unprofitability (with a projected full-year 2026 loss of -$0.44 per share) and volume declines in its Commercial segment. While insider buying from the CEO and CFO signals internal confidence, a 'Hold' recommendation is warranted until the transit divestiture closes and operational stabilization becomes more visible.

This section is the 12-month view: analyst targets and the probability-weighted scenarios built from them. The intrinsic value at the top of this page answers a different question: what the business is worth today.

Street view · analyst 12-month targets2 analysts · as of 18 Aug 2026

Low · most bearish analyst$5.00

Mean target$5.00

High · most bullish analyst$5.00

Our research · scenarios, merits, risks, and invalidation triggersResearch as of 20 Jun 2026

Scenarios · 12-month scenario targetsAnchored at research date

Bear CaseDownside scenario

The sale of the Public Transit business faces regulatory delays or closing adjustments that reduce net proceeds. Volume erosion with major commercial clients accelerates, offsetting growth in the government sector. High leverage and persistent unprofitability continue to weigh on investor sentiment, preventing a valuation re-rating.

Base CaseCentral scenario

The divestiture of the Public Transit business to Modaxo closes successfully by late 2026, providing $164 million in gross proceeds to reduce leverage and fund core operations. Cost-cutting initiatives and GenAI integrations successfully expand Adjusted EBITDA margins toward the upper end of the 2026 guidance. Commercial segment declines stabilize, and the Government and Transportation segments continue their modest growth trajectories.

Bull CaseUpside scenario

Conduent's bull case centers on its aggressive portfolio rationalization and operational streamlining. By divesting non-core, lower-margin assets—such as the sale of its Public Transit business for $164 million and its Tolling business for $70 million—the company is simplifying its operating structure, reducing debt, and enhancing financial flexibility. Furthermore, aggressive cost-cutting initiatives, process automation, and the introduction of AI-powered capabilities are expected to drive margin expansion and stabilize earnings predictability even amidst flat to slightly declining revenues.

Scenarios are anchored to street consensus at the research date, with our probabilities and rationale.

Key Investment Merits

Strategic portfolio simplification, highlighted by the $164 million sale of the Public Transit business to Modaxo.
Strong insider alignment, evidenced by open-market stock purchases by the CEO and CFO in early 2026.
Expanding margins, with Q1 2026 Adjusted EBITDA margin up 190 basis points year-over-year to 6.8%.
Robust new business pipeline of $3.5 billion, representing a 10% year-over-year increase.

Key Investment Risks

Persistent unprofitability, with analysts projecting a full-year 2026 loss of -$0.76 per share.
Revenue contraction in the Commercial segment, driven by volume declines with major clients.
Execution and integration risks associated with ongoing cost-reduction and AI initiatives.

Thesis Invalidation Triggers

Failure to close the Public Transit business sale to Modaxo under the agreed terms.
A material downward revision of the FY 2026 revenue guidance ($2.8B–$2.9B) or Adjusted EBITDA guidance ($160M–$190M).
Significant acceleration of client attrition in the Commercial segment.

All scenarios are estimates and subject to change. Past performance is not indicative of future results.

Quality Pillars Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Explore this dossier

ValuationIntrinsic value, the six-method breakdown, peer medians, and your assumptions sandbox.Financial SnapshotRevenue, profitability, returns, balance sheet, dividends, and the filing-level detail.Qualitative AnalysisBusiness overview, strategic initiatives, and mergers, acquisitions & partnerships.Outlook & Key DatesForward estimates, reporting calendar, and the monitoring framework.